30 years of historical data (1996–2025) · Consumer Cyclical · Specialty Retail
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Natural Health Trends Corp. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $37M | $36M | $53M | $67M | $39M | $77M | $57M | $58M | $209M | $171M | $283M |
| Enterprise Value | $33M | $32M | $42M | $14M | $-26362110 | $-3449760 | $-31537480 | $-34330020 | $77M | $36M | $158M |
| P/E Ratio → | -41.72 | — | 92.77 | 118.15 | 125.18 | 71.16 | 67.48 | — | 6.75 | 7.27 | 5.14 |
| P/S Ratio | 0.93 | 0.89 | 1.24 | 1.53 | 0.80 | 1.29 | 0.92 | 0.75 | 1.09 | 0.87 | 0.99 |
| P/B Ratio | 1.57 | 1.52 | 1.61 | 1.61 | 0.78 | 1.30 | 0.84 | 0.78 | 2.33 | 1.89 | 3.44 |
| P/FCF | — | — | — | — | — | 97.63 | 33.99 | — | 7.09 | 6.50 | 5.42 |
| P/OCF | — | — | — | — | — | 76.01 | 30.18 | — | 7.04 | 6.43 | 5.33 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.80 | 0.98 | 0.33 | -0.54 | -0.06 | -0.51 | -0.44 | 0.40 | 0.18 | 0.55 |
| EV / EBITDA | — | — | — | — | — | -1.84 | -29.23 | — | 2.24 | 0.82 | 2.44 |
| EV / EBIT | — | — | — | — | — | -2.20 | -47.14 | — | 2.22 | 0.83 | 2.46 |
| EV / FCF | — | — | — | — | — | -4.36 | -18.84 | — | 2.60 | 1.36 | 3.01 |
Margins and return-on-capital ratios measuring operating efficiency
Natural Health Trends Corp. earns an operating margin of -4.5%, below the Consumer Cyclical sector average of 2.4%. A negative ROE of -3.1% indicates the company is currently destroying shareholder equity.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 73.5% | 73.5% | 74.0% | 74.6% | 74.2% | 75.0% | 72.6% | 74.1% | 79.5% | 80.4% | 80.9% |
| Operating Margin | -4.5% | -4.5% | -3.0% | -3.8% | -0.5% | 2.6% | 1.1% | -9.0% | 17.6% | 21.8% | 22.3% |
| Net Profit Margin | -2.2% | -2.2% | 1.3% | 1.3% | 0.6% | 1.8% | 1.4% | -7.2% | 16.2% | 11.9% | 19.1% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -3.1% | -3.1% | 1.5% | 1.2% | 0.6% | 1.7% | 1.2% | -6.8% | 34.4% | 27.2% | 79.1% |
| ROA | -1.9% | -1.9% | 0.9% | 0.7% | 0.3% | 1.1% | 0.8% | -4.1% | 19.6% | 15.3% | 40.5% |
| ROIC | -6.5% | -6.5% | -17.9% | — | — | — | — | — | — | — | — |
| ROCE | -6.1% | -6.1% | -3.1% | -3.0% | -0.4% | 2.0% | 0.8% | -6.8% | 29.0% | 41.3% | 83.6% |
Solvency and debt-coverage ratios — lower is generally safer
The company holds a net cash position — cash of $7M exceeds total debt of $3M, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.13 | 0.13 | 0.08 | 0.08 | 0.08 | 0.05 | 0.06 | 0.04 | — | — | — |
| Debt / EBITDA | — | — | — | — | — | 1.69 | 3.65 | — | — | — | — |
| Net Debt / Equity | — | -0.16 | -0.33 | -1.27 | -1.31 | -1.36 | -1.31 | -1.24 | -1.48 | -1.49 | -1.53 |
| Net Debt / EBITDA | — | — | — | — | — | -43.14 | -81.95 | — | -3.88 | -3.10 | -1.95 |
| Debt / FCF | — | — | — | — | — | -101.99 | -52.82 | — | -4.50 | -5.14 | -2.41 |
| Interest Coverage | — | — | — | — | — | — | — | — | — | — | — |
Net cash position: cash ($7M) exceeds total debt ($3M)
Short-term solvency ratios and asset-utilisation metrics
Natural Health Trends Corp.'s current ratio of 2.50x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The current ratio has declined from 3.21x to 2.50x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.50 | 2.50 | 2.45 | 3.21 | 3.79 | 3.79 | 4.64 | 4.12 | 3.49 | 3.61 | 2.47 |
| Quick Ratio | 2.35 | 2.35 | 2.29 | 3.00 | 3.57 | 3.58 | 4.46 | 3.88 | 3.20 | 3.41 | 2.27 |
| Cash Ratio | 2.11 | 2.11 | 2.11 | 2.81 | 3.41 | 3.40 | 4.29 | 3.65 | 3.08 | 3.23 | 2.20 |
| Asset Turnover | — | 1.04 | 0.78 | 0.64 | 0.59 | 0.61 | 0.59 | 0.65 | 1.22 | 1.24 | 1.94 |
| Inventory Turnover | 5.14 | 5.14 | 3.42 | 2.60 | 2.80 | 2.86 | 4.50 | 3.14 | 3.24 | 4.60 | 4.88 |
| Days Sales Outstanding | — | — | — | — | — | — | — | — | — | — | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Natural Health Trends Corp. returns 25.0% to shareholders annually primarily through dividends.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 25.0% | 25.9% | 17.4% | 13.7% | 23.3% | 11.8% | 16.1% | 12.6% | 15.1% | 10.1% | 2.4% |
| Payout Ratio | — | — | 1610.7% | 1622.4% | 2919.5% | 842.2% | 1084.0% | — | 101.5% | 73.0% | 12.5% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | 1.1% | 0.8% | 0.8% | 1.4% | 1.5% | — | 14.8% | 13.8% | 19.4% |
| FCF Yield | — | — | — | — | — | 1.0% | 2.9% | — | 14.1% | 15.4% | 18.4% |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 17.3% | 0.0% | 0.0% | 8.4% |
| Total Shareholder Yield | 25.0% | 25.9% | 17.4% | 13.7% | 23.3% | 11.8% | 16.1% | 29.9% | 15.1% | 10.1% | 10.8% |
| Shares Outstanding | — | $11M | $11M | $11M | $11M | $11M | $11M | $11M | $11M | $11M | $11M |
Compare NHTC with 7 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| NHTCYou | $37M | -41.7 | — | — | 73.5% | -4.5% | -3.1% | -6.5% | — |
| ULTA | $31B | 27.0 | 17.6 | 32.5 | 38.8% | 14.0% | 50.4% | 33.2% | 1.0 |
| BBWI | $5B | 6.3 | 5.9 | 7.4 | 44.3% | 17.3% | — | 32.9% | 3.2 |
| YSG | $3B | -4.4 | — | — | 77.1% | -12.4% | -19.7% | -10.9% | — |
| SBH | $2B | 8.5 | 7.0 | 9.1 | 51.6% | 8.9% | 27.5% | 11.4% | 3.7 |
| OLPX | $1B | 54.9 | 9.5 | 7.6 | 69.2% | 15.8% | 2.3% | 5.1% | 5.4 |
| HNST | $316M | -20.0 | — | 23.2 | 33.3% | -5.0% | -9.1% | -13.5% | — |
| JWEL | $5M | -0.6 | — | 7.6 | 1.0% | -6.1% | -37.8% | -28.0% | — |
| Consumer Cyclical Median | — | 18.8 | 11.0 | 14.0 | 38.6% | 2.4% | 6.5% | 5.6% | 4.2 |
Peers based on L4 peer group classification. Compare multiple stocks →
Includes 30+ ratios · 30 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how NHTC stacks up against sector leader Ulta Beauty, Inc..
Start ComparisonNatural Health Trends Corp.'s current P/E ratio is -41.7x. The historical average is 40.0x.
Natural Health Trends Corp.'s return on equity (ROE) is -3.1%. The historical average is 9.1%.
Based on historical data, Natural Health Trends Corp. is trading at a P/E of -41.7x. Compare with industry peers and growth rates for a complete picture.
Natural Health Trends Corp.'s current dividend yield is 25.04%.
Natural Health Trends Corp. has 73.5% gross margin and -4.5% operating margin.